Role of tumour necrosis factor α in experimental arthritis: Separate activity of interleukin 1β in chronicity and cartilage destruction

Annals of the Rheumatic Diseases

Volumn 58, Issue SUPPL. 1, 1999, Pages

  Van Den Berg, Wim B ^b   Joosten, Leo A B ^b   Kollias, George ^a   Van De Loo, Fons A J ^b  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING AGENT; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL ARTHRITIS; CARTILAGE DEGENERATION; CHRONIC ARTHRITIS; CHRONICITY; CYTOKINE PRODUCTION; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS INFECTION;

ANIMALS; ANTIGENS, BACTERIAL; ARTHRITIS; CARTILAGE, ARTICULAR; CHRONIC DISEASE; COLLAGEN; DISEASE MODELS, ANIMAL; INTERLEUKIN-1; MICE; STREPTOCOCCUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032705651     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Firestcin GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis. Arthritis Rheum 1990;33:768-73.
2. Feldmann M, Brennan F, Maini RN. Rule of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
3. Arend WP, Dayer JM. Inhibition of the production and effects of IL-1 and TNFI in RA. Arthritis Rheum 1995;38: 151-60.
4. Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human rumor necrosis factor: A predictive genetic model of arthritis. EMBO J 1993;10:4025-31.
5. Bresnihan B, Alvaro-Garcia JM, Cobby M, et al. Treatment of rheumatoid arthritis with recombinant human IL-I receptor antagonist. Arthritis Rheum 1998;41:2196-204.
6. Saklatvala J. Tumor necrosis factor a stimulates resorption and inhibits synthesis of protetoglycan in cartilage. Nature 1986;322:547-9.
7. Van de Loo AAJ, van den Berg WB. Effects of murine recombinant IL-1 on synovial joints in mice: Measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 1990;49:238-45.
8. Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and TNFI in the rabbit; evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989;75:306-10.
9. Chabaud M, Durand JM, Buchs N, et al. Human IL-17 A T cell derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999;42:963-70.
10. Ghivizzani SC, Kang R, Georgescu HI, et al. Constitutive intra-articular expression of human IL-1β following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. J Immunol 1997;159: 3604-12.
11. Niki Y, Yadmada H, Kikuchi T, Takaishi H, Fujikawa K, Tada N. Membrane associated TL-1 contributes to chronic synovitis in human IL-1ra transgenic mice. Arthritis Rheum 1998;41:S212.
12. Probert L, Plows D, Kontogeorgos G, Kollias G. The type I IL-1 receptor acts in series with TNFI to induce arthritis in TNFI transgenic mice. Eur J Immunol 1995;25:1794-7.
13. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F Kollias G. Impaired on/off regulation of TNf biosynthesis in mice lacking TNF AU-rich elements:implications for joint and gut associated immunopathologies. Immunity 1999;10:387-98.
14. Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen induced arthritis. Eur J Immunol 1996;26:1511-18.
15. Joosten LAB, Lubberts E, Durez P, et al. Role of IL-4 and IL-10 in murine collagen-induced arthritis: protective effect of IL-4 and IL-10 treatment on cartilage destruction. Arthritis Rheum 1997;40:249-60.
16. van den berg WB, Joosten LAB, Murine collagen induced arthritis. In: Morgan DW, Marshall LA, eds. In vivo models of inflammation. Basle:Birkhauser Verlag, 1999:51-71.
17. Joosten LAB, Lubberts E, Helsen MMA, van den Berg WB: Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol 19997;159:4094-102.
18. Marinova -Mutafchieva L, Williams RO, Mason LJ, et al. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen induced arthritis. Clin Exp Immunol 1997;107:507-12.
19. Williams RO, Feldmann M, Maini RN. Anti-TNF ameliorates joint disease in murine collagen induced arthritis. Proc Natl Acad Sci USA 1992;89:9784-8.
20. Wooley PH, Dutcher J, Widmer MB, Gillis S. Influence of a recombinant human soluble TNF receptor Fc fusion protein on type II collagen induced arthritis in mice. J Immunol 1993,151:6602-7.
21. Van den Berg WB, Joosten LAB, Helsen MMA, van de Loo AAJ. Amelioration of established murine collagen induced arthritis with anti-TL-1 treatment. Clin Exp Immunol 1994;95:237-13.
22. Joosten LAB, Helsen MMA, van de Loo FAJ, van den Berg WB, Amicytokine treatment of established type II collagen-induced arthritis in DBA/1 mice; a comparative study using anti-TNFI, anti-IL-1I/β, and IL-1ra, Arthritis Rheum 1996;39:797-809.
23. Ku G, Faust T, Lauffer LL, Livingston DJ, Harding MW. IL-1β converting enzyme inhibition blocks progression of type II collagen induced arthritis in mice. Cytokine 1996;8:377-86.
24. Bendele A, McAbee T, Senello G, Frazier J, Chlipapa E, McCabe H. Efficacy of sustained blood levels of IL-1ra in animal models of arthritis. Comparison of efficacy in animal models with human clinical data. Arthritis Rheum 1999;42:498-506.
25. Bakker AC, Joosten LAB, Arntz OJ, et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human IL-1ra protein in the knee. Arthritis Rheum 1997;40:893-900.
26. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNFI-deficient mice: A critical requirement for TNFI in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996;184:1397-411.
27. Alexopoulou L, Pasparakis M, Kollias G. Complementation of lymphotoxin alpha knockout mice with TNf expressing transgenes rectifies defective splenic structure and fucntion. J Exp Med 1998;17:745-54.
28. Mori L, Iselin S, De Libero G, Lesslauer W. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice. J Immunol 1996;157:3178-82.
29. van Lent PLEM, van de Loo FAJ, Holthuysen AEM, van den Bersselaar LAM, Vermeer H, van den Berg WB. Major role for IL-1 but not for TNF in early cartilage damage in immune complex arthritis in mice. J Rheumatol 1995;22: 2250-8.
30. Joosten LAB, Helsen MMA, Saxne T, van de Loo FAJ, Heinegard D, van den Berg WB. IL-1I, J blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNFJ blockade only ameliorates joint inflammation. J Immunol (in press).
31. Kassiotis G, Pasparakis M, Kollias G, Probert L. TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein induced experimental autopimmune encephalomyelitis. Eur J Immunol 1999;29: 774-80.
32. Van de Loo AAJ, Joosten LAB, van Lent PLEM, Arntz OJ, van den Berg WB. Role of interleukin-1, tumor necrosis factor I and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ cytokine blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 1995;38:164-72.
33. Lubberts E, Joosten LAB, Helsen MMA, van den Berg WB. Regulatory role of IL-10 in joint inflammation and cartilage destruction in mutine streptotoccal cell wall (SCW) arthritis. More therapeutic; benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone. Cytokine 1998;10:361-9.
34. Kuiper S, Joosten LAB, Bendele AM, et al. Different roles of TNFI and IL-1 in murine streptococcal cell wall arthritis. Cytokine 1998-10:690-702.
35. Zheng H, Fletcher D, Kuzak W, et al. Resistance to fever induction and impaired acute-phase response in IL-1J-deficient mice. Immunity 1995;3:9-19.
36. Van den Berg WB, Joosten LAB, Kollias G, van de Loo FAJ, Helsen MMA. TNF independent role of TL-1J in cartilage destruction in SCW arthritis: evidence form TNFI and IL-1J deficient mice. J Clin Invest (in press).
37. Georgopoulos S, Plows D, Kollias G. Transmembrane TNF is sufficient to induce localized tissue toxity and chronic inflammatory arthritis in transgenic mice. J Inflamm 1996; 46:86-97.
38. Lens JW, van den Berg WB, van de Putte LBA, Zwarts WA. Flare-up of antigen induced arthritis in mice after challenge with intravenous antigen: kinetic of antigen in the circulation and localization of antigen in the arthritic and noninflamed joint. Arthritis Rheum 1986;29:665-74.
39. Van de Loo AAJ, Arntz OJ, Bakker AC, van Lent PLEM, Jacobs MJM, van den Berg WB. Role of interleukin-1 in antigen-induced exacerbations of murine arthritis. Am J Pathol 1995;146:239-49.
40. Van de Loo AAJ, Arntz OJ, van den Berg WB. Flare-up of experimental arthritis in mice with murine recombinant IL-1. Clin Exp Immunol 1992;87:196-202.
41. Makarov SS, Olsen JC, Johnston WN, et al. Suppression of experimental arthritis by gene transfer of IL-1ra cDNA. Proc Natl Acad Sci USA 1996;3:402-6.
42. Marino MW, Dunn A, Grail D, et al. Charaacterization of TNF-deficient mice. Proc Natl Acad Sci USA 1997;94: 8093-8.
43. Fantuzzi G, Ku G, Harding MW, et al. Response to local inflammation in IL-1b converting enzyme deficient mice. J Immunol 1997;158:1818-24.
44. Labow M, Shuster D, Zetterstrom M, et al. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor deficient mice. J Immunol 1997;159:2452-61.
45. William R, Watson G, Rotstein OD, Parudo J, Hitar R, Marshall JC. The IL-1b converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1b. J Immunol 1998;161:957-62.
46. Van Meurs JBJ, van Lent PLEM, Holthuysen AEM, Singer II, Bayne EK, van den Berg WB. Kinetics of aggrecanase and metalloproteinase induced neoepitopes in various stages of cartilage destruction in murine arthritis. Arthritis Rheum 1999;42:1128-39.
47. Van Meurs JBJ, van Lent PLEM, Singer II, Bayne EK, van de Loo FAJ, van den Berg WB. IL-1ra prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis. Arthritis Rheum 1998;41:647-56.
48. Van Meurs JBJ, van Lent PLEM, Holthuysen AEM, et al. Cleavage ofaggrecan at Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: A pivotal role for stromelysin-1 in MMP activity. Arthritis Rheum (in press).
49. Burger D, Rezzonico R, Li JM, et al. Imbalance between interstitial collagenase and TIMPI in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes. Involvement of membrane associated cytokine. Arthritis Rheum 1998;41:1748-59.
50. Brennan FM, Chantry D, Jackson A, Maini RN, Feldmann M. Inhibitory effect of TNFI antibodies on synovial cell IL-1 production in rheumatoid arthritis. Lancet 1989;ii: 244-7.
51. Deleuran B. Cytokines in RA; localization in arthritic joint tissue and regulation in vitro. Scand J Rheumaol 1996;25 (suppl 104):1-38.
52. Kirkham B, Portek I, Lee CS, et al. Intrarticular variability of synovial membrane histology, immunohistology, and cytokine mRNA expression in patients with rheumatoid arthritis. J Rheumatol 1999;25:777-84.